Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/22/10 | Current report filing |
|
90 | ||
| 04/22/10 | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
3 | ||
| 04/22/10 | Prospectus filed pursuant to Rule 424(b)(5) |
|
68 | ||
| 04/12/10 | Prospectus filed pursuant to Rule 424(b)(3) |
|
68 | ||
| 04/06/10 | Prospectus filed pursuant to Rule 424(b)(3) |
|
67 | ||
| 03/12/10 | Notice of Effectiveness |
|
1 | ||
| 03/03/10 | Registration statement for specified transactions by certain issuers |
|
68 | ||
| 03/03/10 | Annual report pursuant to Section 13 and 15(d) |
|
90 | ||
| 02/25/10 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
10 | ||
| 02/17/10 | Statement of changes in beneficial ownership of securities |
|
1 |